From: Plasma copeptin level in type 2 diabetic patients and its role in diabetic nephropathy
 | Group I (Control) [N= 15] | Group II DM with (Normo) [N= 15] | Group III DM with (Micro) [N= 15] | Group IV DM with (Macro) [N= 15] | Test of Significance |
---|---|---|---|---|---|
Sex (F/M) | 5/10 | 5/10 | 7/8 | 6/9 | P = 0.126 |
Age (years) | 56.27 ± 6.22 | 54.87 ± 5.74 | 54.20 ± 6.86 | 58.13 ± 6.06 | P = 0.330 |
BMI (Kg/m2) | 28.73 ± 4.20 | 30.67 ± 4.97 | 31.33 ± 3.31 | 32.53 ± 4.14 | P = 0.104 |
SBP (mmHg) | 124.67 ± 11.87 | 134.00 ± 19.19 | 135.33 ± 14.07 | 141.33 ± 21.99 | P = 0.078 |
DBP (mmHg) | 78.67 ±10.60 | 82.00 ± 14.28 | 85.33 ± 14.07 | 88.67 ± 13.55 | P = 0.201 |
Duration of DM (years) | ………….. | 7.73 ± 4.44 | 9.40 ± 4.37 | 13.40 ± 4.45 | P < 0.001* |
BUN (mg/dl) | 14.53 ± 2.84 | 15.91 ± 2.96 | 41.85 ± 2.39 | 62.91 ± 4.91 | P < 0.001* |
Serum creatinine (mg/dl) | 0.97 ± 0.21 | 1.38 ± 0.18 | 1.72 ± 0.16 | 2.85 ± 0.36 | P < 0.001* |
eGFR (ml/min/1.73 m 2 ) | 92.18 ± 2.13 | 90.52 ± 8.22 | 78.23 ± 4.81 | 58.19 ± 6.69 | P < 0.001* |
UACR (mg/g cr) | 23.49 ± 3.82 | 25.82 ± 3.45 | 184.66 ± 75.10 | 332.80± 12.77 | P < 0.001* |
Fasting blood glucose level (mg/dl) | 99.73 ± 8.89 | 122.68 ± 26.25 | 138.74 ± 25.14 | 176.50 ± 27.75 | P < 0.001* |
2-h postprandial glucose level (mg/dl) | 130.07± 18.39 | 181.50 ± 38.17 | 220.08 ±45.19 | 264.50 ± 65.17 | P < 0.001* |
HbA1C (%) | 5.48 ± 0.719 | 6.44 ± 0.93 | 8.45 ± 0.38 | 9.57 ± 0.27 | P < 0.001* |
Triglycerides (mg/dl) | 138.80 ± 35.83 | 146.73 ± 45.61 | 171.47 ± 44.18 | 197.43 ± 42.88 | P = 0.016* |
Total cholesterol (mg/dl) | 136.13 ± 12.14 | 171.13 ± 38.93 | 213.07 ± 56.09 | 222.73 ± 59.83 | P = 0.024* |
HDL-C (mg/dl) | 58.80 ± 10.56 | 51.87 ± 12.57 | 43.73 ± 11.24 | 39 .27 ± 9.60 | P < 0.001* |
LDL-C (mg/dl) | 103.07 ±19.41 | 112.87 ± 31.58 | 129.53 ± 38.38 | 136.07 ± 35.25 | P = 0.005* |
Copeptin (pmol/L) | 2.09 ± 0.50 | 2.92 ± 0.71 | 4.11 ± 0.83 | 4.98 ± 0.72 | P < 0.001* |